false
OasisLMS
Login
Hamburger Menu
Catalog
The Lead Episode 8: A Discussion of Individualized ...
The Lead Episode 8: A Discussion of Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy
Description
Andrew D. Krahn, MD, FHRS discusses this article with guests Jason D. Roberts, MD and Julia Cadrin-Tourigny, MD, PhD, CCDS. Clinical guidelines recommend regular screening for arrhythmogenic right ventricular cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. Prioritizing relatives on their probability of developing definite ARVC may provide more efficient patient care.
Learning Objectives
The aim of this study was to determine the predictors and probability of ARVC development over time among at-risk relatives.
Article Authors and Podcast Contributors
Article Authors
Steven A. Muller, Alessio Gasperetti, Laurens P. Bosman, Amand F. Schmidt, Annette F. Baas, Ahmad S. Amin, Arjan C. Houweling,Arthur A.M. Wilde, Paolo Compagnucci, Mattia Targetti, Michela Casella, Leonardo Calò, Claudio Tondo, Pim van der Harst, Folkert W. Asselbergs, J. Peter van Tintelen, Marish I.F.J. Oerlemans, Anneline S.J.M. te Riele
Podcast Contributors
Andrew D. Krahn, MD, FHRS
of University of British Columbia
Jason D. Roberts, MD
of McMaster University
Julia Cadrin-Tourigny, MD, PhD, CCDS
of Montreal Heart Institute
Disclosure Policy
All relevant financial relationships have been mitigated.
Host Disclosure(s):
A. Krahn:
Honoraria/Speaking/Consulting Fee: Medtronic, Inc
Contributor Disclosure(s):
J. Roberts:
Honoraria/Speaking/Consulting Fee: Ionis Pharmaceuticals
J.
Cadrin-Tourigny
:
Honoraria/Speaking/Consulting Fee: BMS/Pfizer Alliance, Bayer Healthcare Pharmaceuticals, Tenaya Therapeutics
Staff Disclosu
re(s)
(note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn:
No relevant financial relationships with ineligible companies to disclose.
S. Sailor:
No relevant financial relationships with ineligible companies to disclose.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
The Lead Episode 8: A Discussion of Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy Course List
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 66: Class 1C Antiarrhythmics for Premature Ventricular Complex Suppression in Nonischemic Cardiomyopathy with Implantable Cardioverter-Defibrillators
Multiple Credits
FREE
(1)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Heart Rhythm 2024 On Demand - Clinical Electrophysiology
Multiple Credits
$299.00 - $399.00
(1)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Heart Rhythm 2024 On Demand - Ablation
Multiple Credits
$249.00 - $349.00
Learning Activity Title
Learning Activity Title
Learning Activity Title
Heart Rhythm 2024 On Demand – Various Sessions
Multiple Credits
$249.00 - $349.00
(1)
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 50: New-onset atrial fibrillation prediction: the HARMS2-AF risk score
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 1: A Discussion of Left Bundle Branch Area Pacing Versus Biventricular Pacing as the Initial Implant Strategy for Cardiac Resynchronization Therapy
No Credit
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Heart Rhythm 2023 On Demand - Clinical Electrophysiology
Multiple Credits
$249.00 - $349.00
(5)
Learning Activity Title
Learning Activity Title
Learning Activity Title
HRS365 Passport: Physicians
Multiple Credits
$1,599.00 - $1,799.00
(6)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Core Concepts in Remote Monitoring Module 1: The Current State of Remote Monitoring in EP
Multiple Credits
$99.00 - $125.00
(7)
Login
×
Please select your language
1
English